MYND Life Sciences Inc
CNSX:MYND
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MYND Life Sciences Inc
CNSX:MYND
|
CA |
|
J
|
Jindal Steel Ltd
BSE:532286
|
IN |
|
A
|
Atea ASA
SWB:MKL
|
NO |
|
Unisia Holdings Co
TSE:3547
|
JP |
|
T
|
Tapestry Inc
F:COY
|
US |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
CH |
|
NWPX Infrastructure Inc
NASDAQ:NWPX
|
US |
|
J
|
Jeronimo Martins SGPS SA
ELI:JMT
|
PT |
|
Soligenix Inc
NASDAQ:SNGX
|
US |
|
Hotel Sahid Jaya International Tbk PT
IDX:SHID
|
ID |
|
Advantest Corp
TSE:6857
|
JP |
|
Belluna Co Ltd
TSE:9997
|
JP |
|
Y
|
Ypsomed Holding AG
XMUN:OWX
|
CH |
|
I
|
International Business Machines Corp
XHAM:IBM
|
US |
|
Greenwood Sejahtera Tbk PT
IDX:GWSA
|
ID |
|
Tenaris SA
F:TW10
|
LU |
|
I
|
Ivestos AG
DUS:LWD
|
DE |
|
Sampo Oyj
OMXH:SAMPO
|
FI |
Bankruptcy Probability
MYND Life Sciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
MYND Life Sciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
M
|
MYND Life Sciences Inc
CNSX:MYND
|
1.7m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Sartorius AG
XETRA:SRT
|
14.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Charles River Laboratories International Inc
NYSE:CRL
|
14.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
|
ICON PLC
NASDAQ:ICLR
|
12.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gartner Inc
NYSE:IT
|
11.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
11.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Cytokinetics Inc
NASDAQ:CYTK
|
8.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
7.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
BACHEM HOLDING AG
SIX:BANB
|
6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Ligand Pharmaceuticals Inc
NASDAQ:LGND
|
5.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
MYND Life Sciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, MYND Life Sciences Inc has total debt of 3m CAD. This includes both short-term (3m CAD) and long-term (0 CAD) debt.
You can find a full breakdown on its Balance Sheet.